After announcing a $100 million Series B+ funding, the biotech company’s CEO tells FinanceAsia it is now in full IPO preparation mode with Hong Kong as its preferred destination. However, a dual listing is not out of the question.
The aluminium extrusion company raises $1.26 billion and becomes the largest IPO so far this year amid good interest from global institutions. Retail investors are less enthusiastic, leaving the Hong Kong public tranche undersubscribed.
The property developer shakes off a profit warning and becomes the first Hong Kong-listed company to do a follow-on offering since mid-February. Meanwhile, Credit Suisse and Morgan Stanley trim their holdings in China Resources Gas.